C
CVS Health Corp.
CVS · NYSE · USD
Historical Earnings
| Quarter | Reported | EPS est | EPS act | Surprise | Rev est | Rev act | Surprise | Reaction |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | 1.85 | 2.58 | +39.5% | $100B | $106B | +6.1% | −2.93% |
| Q1 2026 | May 6, 2026 | 2.18 | 2.57 | +17.9% | $95.0B | $100B | +5.7% | +0.58% |
| Q4 2025 | Feb 10, 2026 | 1.00 | 1.09 | +9.0% | $104B | $106B | +1.9% | +1.74% |
| Q3 2025 | Oct 29, 2025 | 1.37 | 1.60 | +16.8% | $98.8B | $103B | +4.1% | −4.85% |
| Q2 2025 | Jul 31, 2025 | 1.46 | 1.81 | +24.0% | $94.5B | $98.9B | +4.6% | +0.60% |
| Q1 2025 | May 1, 2025 | 1.70 | 2.25 | +32.4% | $93.7B | $94.6B | +1.0% | −2.87% |
| Q4 2024 | Feb 12, 2025 | 0.91 | 1.19 | +30.2% | $97.1B | $97.7B | +0.6% | +4.98% |
| Q3 2024 | Nov 6, 2024 | 1.44 | 1.09 | −24.3% | $92.7B | $95.4B | +2.9% | −7.37% |
Detailed View
Q3 2026Nov 4, 2026Q2 2026Aug 5, 2026−2.93%Q1 2026May 6, 2026+0.58%Q4 2025Feb 10, 2026+1.74%Q3 2025Oct 29, 2025−4.85%Q2 2025Jul 31, 2025+0.60%Q1 2025May 1, 2025−2.87%Q4 2024Feb 12, 2025+4.98%Q3 2024Nov 6, 2024−7.37%Q2 2024Aug 7, 2024Q1 2024May 1, 2024Q4 2023Feb 7, 2024
2026 Q2 Metrics
| Metric | Estimate | Actual | Surprise | Y/Y |
|---|---|---|---|---|
| Revenue | $100B | $106B | Beat +6.07% | +7.3% |
| EPS | 1.85 | 2.58 | Beat +39.46% | +42.5% |
| Diluted EPS (GAAP) | — | 2.31 | — | +188.8% |
Documents
- Earnings call transcript — Q2 2026Transcript · Aug 5, 2026 · 45 speaker turns
- 8-K — Q2 20268-K · Aug 17, 2026 · sec.gov
- 8-K — Q2 20268-K · Aug 5, 2026 · sec.gov
- 10-Q — Q2 202610-Q · Aug 5, 2026 · sec.gov